RIV Capital Records Rising Losses, Remains Bullish on New York

The company is showing a strong year-end liquidity standing of $97.9 million.

RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) posted the results of its fourth quarter and fiscal year ended March 31, 2023. Even with the difficulties facing the New York cannabis market, the company is maintaining an optimistic long-term stance.

RIV reported total revenue of $1.8 million during the quarter, which declined from the third quarters’ revenue of $2 million. The company had an operating loss of $5 million. Riv said that the medical cannabis market in New York has declined due to the proliferation of unlicensed cannabis stores.

Net losses grew from the previous quarter’s $9.9 million to a current loss of $23.6 million. The figure is a notable rise from the fourth quarter of the previous year, which saw a loss of $13.7 million. A significant portion of the loss is linked to a $16 million charge that was settled on Feb. 23.

Looking at the next two years, the company intends to make sizeable investments in New York. However, CFO Eddie Lucarelli is confident about the company’s financial health.

“Even after these cash outlays, the company will remain in a strong financial position to execute on M&A and other investment opportunities,” Lucarelli said in a statement Wednesday.

Interim CEO and COO Mike Totzke admitted to the slower than expected progress in the opening of New York’s adult-use market. Still, Totzke remains positive.

“We remain bullish on this market’s long-term prospects, especially in light of the recently unveiled updated draft regulations that we believe are a much-needed move in the right direction,” Totzke said.

RIV Capital has been making major progress with Etain from an operational perspective. Additionally, RIV Capital is progressing with the development of a new flagship facility in Buffalo, New York.

Looking at the retail angle, the firm is working to expand distribution points. Currently, Etain products are available in 75% of medical dispensaries across New York state.

And despite the fiscal losses, the company is showing a strong year-end liquidity standing of $97.9 million. The fiscal solidity is expected to help RIV Capital make substantial inroads into the New York cannabis market. The company plans to leverage the financial position to secure a significant portion of the market, with an eye on entering the adult-use market later this year.

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.